Industrial solvents and kidney disease

International Journal of Occupational and Environmental Health

Volumn 10, Issue 1, 2004, Pages 79-83

  Brautbar, Nachman ^a  

^a UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

Author keywords

Glomerulonephritis; Industrial solvents; Kidney disease

Indexed keywords

FUEL; GASOLINE; HYDROCARBON; PAINT; SOLVENT; TURPENTINE;

GLOMERULONEPHRITIS; GOODPASTURE SYNDROME; HUMAN; INGESTION; INHALATION; KIDNEY DISEASE; MEMBRANOUS GLOMERULONEPHRITIS; METABOLISM; NONHUMAN; OCCUPATIONAL EXPOSURE; PATHOGENESIS; PHYSICIAN; PRIORITY JOURNAL; PROLIFERATIVE GLOMERULONEPHRITIS; REVIEW; RISK FACTOR; SKIN ABSORPTION; ANIMAL; CASE CONTROL STUDY; CHEMICALLY INDUCED DISORDER; OCCUPATIONAL DISEASE;

ANIMALS; CASE-CONTROL STUDIES; GLOMERULONEPHRITIS; HUMANS; HYDROCARBONS; OCCUPATIONAL DISEASES; OCCUPATIONAL EXPOSURE;

EID: 3943094715     PISSN: 10773525     EISSN: None     Source Type: Journal    
DOI: 10.1179/oeh.2004.10.1.79     Document Type: Review

References (59)

1. Morrison RR, Boyd RN. Organic Chemistry. 5th ed. Boston, MA: Allyn & Bacon, 1987.
2. Domask WG, Mehlman MA, Hemstreet GP III, Thorpe JJ, Weaver NK (eds). Renal Effects of Petroleum Hydrocarbons. Princeton, NJ: Princeton Scientific Publishers, 1984: 1-25.
3. Pederen LM. Biological studies in human exposure to and poisoning with organic solvents. Pharmacol Toxicol. 1987; 3: 1-38.
4. Ervin ME, Haddad LM, Winchester JF (eds). Clinical Management of Poisoning and Drug Overdose. Philadelphia, PA: W. B. Saunders, 1983: 771.
5. Wolfsdorf J, Paed D. Kerosene intoxication: an experimental approach to the etiology of the CNS manifestations in primates. J Pediatr. 1987; 88: 1037.
6. Janssen S, Van der Geest S, Meijer S, Uges DRA. Impairment of organ function after oral ingestion of refined petrol. Intens Care Med. 1988; 14: 238-40.
7. Smith TC, Wollman H, Goodman A, Gilman L (eds). The Pharmacological Basis of Therapeutics. New York: Macmillan, 1985: 260-75.
8. Clayton GD, Clayton EE (eds). Patty's Industrial Hygiene and Toxicology. New York: Wiley, 26 1981 and 2C 1982.
9. World Health Organization and Nordic Council of Ministers. Organic solvents and the central nervous system. Environmental Health (Copenhagen and Oslo). 1985; 5:1-135.
10. Browning E. Toxicity and Metabolism of Industrial Solvents. Amsterdam, The Netherlands, London, U.K., New York: Elsevier, 1965.
11. Mehlman MA, Hemstreet GP III, Thorpe JJ, Weaver NK. Renal effects of petroleum hydrocarbons. In: Advances in Modern Environmental Toxicology: Volume VII. Princeton, NJ: Princeton Scientific Publishers, 1984.
12. Carpenter CP, Geary DL Jr, Myers D, Nachreiner DJ, Sullivan K, King J. Petroleum hydrocarbon toxicity studies. Toxicol Appl Pharmacol. 1977; 41: 251-60.
13. Gibson JE, Bus JS. Current perspectives on gasoline (light hydrocarbon) induced male rat nephropathy. Ann NY Acad Sci 1988; 534: 481-5.
14. Thomas FB, Halder CA, Holdsworth CE, Cockrell B. In: Back PH, Lock EA (eds). Renal Heterogeneity and Target Cell Toxicit. Chichester, U.K., 1985; 477-80.
15. Halder CA, Van Gorp GS, Hatoum NS, Warne TM. Gasoline vapor exposures. Part 1. Am Ind Hyg Assoc J. 1986; 47: 164-72.
16. Coppo R. The pathogenic potential of environmental antigens in IgA neuropathy. Am J Kidney Dis. 1988; 12: 420-4.
17. Emancipator SN. Immunoregulatory factors in the pathogenesis of IgA nephropathy. Kidney Int. 1990; 38: 1216-29.
18. Churchill DN, Fine A, Gault MH. Association between hydrocarbon exposure and glomerulonephritis. Nephron. 1983; 33: 169-72.
19. Roy A, Brautbar N, Lee D. Hydrocarbons and renal failure. Nephron. 1991; 58: 385-92.
20. Sprerace GA. Idiopathic pulmonary hemosiderosis. Am Rev Respir Dis. 1963; 88: 330-7.
21. Heale WF, Matthisson Am, Niall JF, Lung hemorrhage and nephritis (Goodpasture's syndrome). Med J Aus.t 1969; iii: 355-7.
22. Klavis G, Drommer W. Goodpasture syndrome and the effects of benzene. Arch Toxicol. 1970; 26: 40-50.
23. Beirne G, Brennan J. Glomerulonephritis associated with hydrocarbon solvents. Arch Environ Health. 1972; 25: 365-9.
24. D'Apice AJF, Kincaid-Smith P, Becker GJ, Loughead MG, Freeman JW, Sands JM. Goodpasture's syndrome in identical twins. Ann Intern Med. 1980; 88: 61-2.
25. Kleinknecht D, Morel-Maroger L, Callard P, Adhemar JP, Mahieu P. Antiglomerular basement membrane nephritis after solvent exposure. Arch Intern Med. 1980; 140: 230-2.
26. Daniell WE, Couser WG, Rosenstock L. Occupational solvent exposure and glomerulonephritis: a case report and review of the literature. JAMA. 1988; 259: 2280-3.
27. Von Scheele C, Althoff P, Kempni V, Schelin H. Nephrotic syndrome due to subacute glomerulonephritis - association with hydrocarbon exposure? Acta Med Scand. 1976; 200: 427-9.
28. Ehrenreicht T, Yunis SL, Churg J. Membranous neuropathy following exposure to volatile hydrocarbons. Environ Res. 1977; 24: 35-45.
29. Cagnoli L. Relation between hydrocarbon exposure and the nephrotic syndrome. Lancet. 1980; I: 1068-9.
30. Brautbar N, Barnett A. Hydrocarbon exposure and chronic renal disease. Environ Epidemiol Toxicol. 1992; 2: 163-6.
31. Lagrue G, Kamalodine T, Guerro J, Hirbec G, Zhepova F, Bernaudin JF. Neuropathies glomerulaires primitives et inhalation de substances toxiques. J Urol Nephrol. 1977; 4-5: 323-9.
32. Lagrue G, Kamalodine T, Hirbec G et al. Role of inhalation of toxic substances in the pathogenesis of glomerulonephritis. Nouv Press Med. 1977; 6: 3609-13.
33. Ravnskov U, Forsbergg B, Skerfving S. Glomerulonephritis and exposure to organic solvents: a case control study. Acta Med Scand. 1983; 205: 575-9.
34. Ravnskov U, Lundstrom S, Norden A. Hydrocarbon exposure and glomerulonephritis: evidence from patient's occupations. Lancet .1983; ii: 1214-6.
35. Nuyts GD, Van Viem E, Thys J, et al. New occupational risk factors for chronic renal failure. Lancet. 1995; 346: 7-11.
36. Zimmerman SW, Groehler K, Beirne GJ. Hydrocarbon exposure and chronic glomerulonephritis. Lancet. 1975; ii: 199-201.
37. Ravnskov U. Exposure to organic solvents - a missing link in post-streptococcal glomerulonephritis. Acta Med Scand. 1978; 203: 351-6.
38. Finn R, Fennerty RG, Ahmad R. Hydrocarbon exposure and glomerulonephritis. Clin Nephrol. 1980; 14: 173-5.
39. Van der Laan G. Chronic glomerulonephritis and organic solvents. Int Arch Occup Envion Health. 1980; 47; 1-8.
40. Harrison DJ, Thompson D, MacDonald MK. Membranous glomerulonephritis. J Clin Pathol. 1986; 39: 167-71.
41. Askergren A. Studies on kidney function in subjects exposed to organic solvents. III: Excretion of cells in the urine. Acta Med Scand. 1981; 210: 103-6.
42. Bell GM, Gordon ACH, Lee P, et al. Proliferative glomerulonephritis and exposure to organic solvents. Nephron. 1985; 40: 161-5.
43. Yaqoob M, Bell, G, Stevenson A, Mason H, Percy D. Renal impairment with chronic hydrocarbon exposure. Q J Med. 1993; 86: 165-74.
44. Porro A, Lomonte C, Coratelli P, Passavanti G, Ferri M, Assento G. Chronic glomerulonephritis and exposure to solvents: a case reference study. Br J Ind Med. 1992; 49: 738-42 .
45. De Broe ME, D'Haese PC, Nuyts GD, Elseviers MM. Occupational renal diseases. Curr Opin Nephr Hypertens. 1996; 5: 114-21.
46. Yaqoob M, Bell GM, Percy D, Finn R. Primary glomerulonephritis and hydrocarbon exposure: a case control study and literature review. Q J Med. 1992; 301: 409-18.
47. Goyer RA. Environmentally related diseases of the urinary tract. Med Clin North Am. 1990; 74: 377-89.
48. Landrigan P, Goyer RA, Clarkson TW et al. The work-relatedness of renal disease. Arch Environ Health. 1984; 39: 225-30.
49. Stengel B, Canee S, Linasset JC. Organic solvent exposure may increase the risk of glomerular nephropathies with chronic renal failure. Int J Epidemiol. 1995; 24: 427-34.
50. Steenland NK, Thun MJ, Ferguson BA, Port FK. Occupational and other exposures associated with male end-stage renal disease: a case control study. Am J Public Health. 1990; 80: 153-6.
51. Ravnskov U. Possible mechanisms of hydrocarbon-associated glomerulonephritis. Clin Nephrol. 1985; 23: 294-8.
52. Horiguchi S, Okada H, Horiuchi K. Effects of benzene on the leucocytic function of mice. An approach to the maximum allowable concentration of benzene. Osaka City Med J. 1972; 18: 1.
53. Yamamoto T, Wilson CB. Binding of anti-basement membrane antibody to alveolar basement membrane after intratracheal gasoline instillation in rabbits. Am J Pathol. 1987; 126: 497-505.
54. Emery P, Panayi GS, Huston G, Welsh KI, Mitchell SC, Shah RR. D-Penicillamine induced toxicity in rheumatoid arthritis: the role of sulphoxidation status and HLA-DR3. J Rheumatol. 1984; 11: 626-32.
55. Batchelor JR, Welsh KI, Mansilla-Tinoco R, Dollery CT Hughes GRV, Bernstein R. Hydralazine induced systemic lupus erythematosus: influence of HLA-DR and sex on susceptibility. Lancet. 1984; I: 1107-9.
56. Ravnskov U. Hydrocarbon exposure may cause glomerulonephritis and worsen renal function: evidence based on Hill's criteria for causality. Q J Med. 2000; 93:551-6.
57. Hill AB. The environment and disease: association or causation? President's address. Proc R Soc Med. 1965; 9: 295-300.
58. Tom N (ed). Environmental and Occupational Medicine. Chapter 57. Philadelphia, PA: Lippincott-Raven, 1998.
59. Ravnskov U. Hydrocarbons may worsen renal function in glomerulonephritis: a meta-analysis of the case-control studies. Am J Ind Med. 2000; 37: 599-606.